China Medical & HealthCare Group Limited provided consolidated earnings guidance for the year ended 30 June 2018. The company is expected to record an increase in the loss attributable to shareholders of the Company for the year ended 30 June 2018 as compared with 2017. The expected increase in loss attributable to shareholders of the company for the year ended 30 June 2018 was mainly due to (i) the loss in fair value change of investments held for trading as compared with a gain recorded in 2017; (ii) the reduction in sales of properties under the property development operations; and (iii) the reduction in sales of independent living units ("ILU") under the Eldercare Division, which were partially off-set by the absence of net loss on disposal of subsidiaries in current fiscal year.